Neuroendocrine abnormalities in Parkinson's disease

The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action

(2016) Dilan Athauda et al.   DRUG DISCOVERY TODAY

Hypothalamic α-synuclein and its relation to weight loss and autonomic symptoms in Parkinson's disease

(2016) Eduardo De Pablo-Fernandez et al.   MOVEMENT DISORDERS

Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease

(2016) David P. Breen et al.   MOVEMENT DISORDERS

Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson's disease: Systematic review and meta-analysis

(2016) Tiago Martins Rodrigues et al.   PARKINSONISM & RELATED DISORDERS

Association Between Change in Body Mass Index, Unified Parkinson’s Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease

(2016) Anne-Marie A. Wills et al.   JAMA Neurology

Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial

(2015)   LANCET NEUROLOGY

Weight Loss and Impact on Quality of Life in Parkinson’s Disease

(2015) Umer Akbar et al.   PLoS One

Motor and Cognitive Advantages Persist 12 Months After Exenatide Exposure in Parkinson’s Disease

(2015) Iciar Aviles-Olmos et al.   Journal of Parkinsons Disease

Glitazone Treatment and Incidence of Parkinson’s Disease among People with Diabetes: A Retrospective Cohort Study

(2015) Ruth Brauer et al.   PLOS MEDICINE

Body Mass Index and Risk of Parkinson’s Disease: A Dose-Response Meta-Analysis of Prospective Studies

(2015) Yun-Liang Wang et al.   PLoS One

Assessment and management of fracture risk in patients with Parkinson's disease

(2014) Veronica Lyell et al.   AGE AND AGEING

Improved nutritional status is related to improved quality of life in Parkinson’s disease

(2014) Jamie M Sheard et al.   BMC Neurology

Reduced risk of Parkinson’s disease associated with lower body mass index and heavy leisure-time physical activity

(2014) Katri Sääksjärvi et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

A service development study of the assessment and management of fracture risk in Parkinson’s disease

(2014) Samuel Shribman et al.   JOURNAL OF NEUROLOGY

Bone health in Parkinson's disease: a systematic review and meta-analysis

(2014) Kelli M Torsney et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Adipokines: a link between obesity and dementia?

(2014) Amanda J Kiliaan et al.   LANCET NEUROLOGY

Weight gain following subthalamic nucleus deep brain stimulation: A PET study

(2014) Paul Sauleau et al.   MOVEMENT DISORDERS

Circadian insights into dopamine mechanisms

(2014) J. Mendoza et al.   NEUROSCIENCE

Association between vitamin D receptor gene polymorphisms and susceptibility to Parkinson's disease: A meta-analysis

(2014) Zi-Teng Zhang et al.   NEUROSCIENCE LETTERS

Diabetes is associated with postural and cognitive domains in Parkinson's disease. Results from a single-center study

(2014) Martina Giuntini et al.   PARKINSONISM & RELATED DISORDERS

Diabetes and Risk of Parkinson's Disease: An Updated Meta-Analysis of Case-Control Studies

(2014) Lin Lu et al.   PLoS One

Disturbances in melatonin secretion and circadian sleep–wake regulation in Parkinson disease

(2014) S.J. Bolitho et al.   SLEEP MEDICINE

Circadian Melatonin Rhythm and Excessive Daytime Sleepiness in Parkinson Disease

(2014) Aleksandar Videnovic et al.   JAMA Neurology

Sleep and Circadian Rhythm Regulation in Early Parkinson Disease

(2014) David P. Breen et al.   JAMA Neurology

Mechanisms of Body Weight Fluctuations in Parkinson’s Disease

(2014) Andrea Kistner et al.   Frontiers in Neurology

Elevated homocysteine levels in levodopa-treated idiopathic Parkinson's disease: a meta-analysis

(2013) X.-W. Hu et al.   ACTA NEUROLOGICA SCANDINAVICA

Crosstalk between the circadian clock circuitry and the immune system

(2013) Nicolas Cermakian et al.   CHRONOBIOLOGY INTERNATIONAL

Circadian regulation of renal function and potential role in hypertension

(2013) Olivier Bonny et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Sleep and circadian rhythm disruption in neuropsychiatric illness

(2013) Aarti Jagannath et al.   CURRENT OPINION IN NEUROBIOLOGY

The central circadian timing system

(2013) Clifford B Saper   CURRENT OPINION IN NEUROBIOLOGY

Dietary and lifestyle variables in relation to incidence of Parkinson’s disease in Greece

(2013) Andreas Kyrozis et al.   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: Insights from a transgenic mouse model

(2013) L. David Willison et al.   EXPERIMENTAL NEUROLOGY

Unknown

(2013) Christos Savvidis et al.   MOLECULAR MEDICINE

Hip fractures in people with idiopathic Parkinson's disease: Incidence and outcomes

(2013) Richard W. Walker et al.   MOVEMENT DISORDERS

Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study

(2013) H. Ding et al.   NEUROLOGY

Disturbed sleep in Parkinson's disease: anatomical and pathological correlates

(2013) M. E. Kalaitzakis et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Diabetes is associated with postural instability and gait difficulty in Parkinson disease

(2013) Vikas Kotagal et al.   PARKINSONISM & RELATED DISORDERS

The Relationship between Thermoregulation and REM Sleep Behaviour Disorder in Parkinson’s Disease

(2013) George Zhong et al.   PLoS One

Shared dysregulated pathways lead to Parkinson's disease and diabetes

(2013) Jose A. Santiago et al.   TRENDS IN MOLECULAR MEDICINE

Ghrelin is neuroprotective in Parkinson’s disease: molecular mechanisms of metabolic neuroprotection

(2013) Jacqueline A. Bayliss et al.   Therapeutic Advances in Endocrinology and Metabolism

Dual Roles of Dopamine in Food and Drug Seeking: The Drive-Reward Paradox

(2012) Roy A. Wise   BIOLOGICAL PSYCHIATRY

Effect of co-morbidities on fracture risk: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW)

(2012) Elaine M. Dennison et al.   BONE

Parkinson's disease, insulin resistance and novel agents of neuroprotection

(2012) Iciar Aviles-Olmos et al.   BRAIN

Effects of Circadian Disruption on Mental and Physical Health

(2012) Ilia N. Karatsoreos   Current Neurology and Neuroscience Reports

In search of the neuroprotective mechanism of thiazolidinediones in Parkinson's disease

(2012) Dirk A. Ridder et al.   EXPERIMENTAL NEUROLOGY

Dementia is associated with Insulin Resistance in patients with Parkinson's Disease

(2012) Domenico Bosco et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Diabetes and risk of Parkinson's disease

(2012) Emanuele Cereda et al.   MOVEMENT DISORDERS

Sleep and Parkinson's disease: A review of case-control polysomnography studies

(2012) Tasneem Peeraully et al.   MOVEMENT DISORDERS

Diurnal Variation of Hypothalamic Function and Chronic Subthalamic Nucleus Stimulation in Parkinson's Disease

(2012) Carola Seifried et al.   NEUROENDOCRINOLOGY

Clinical features of Parkinson disease when onset of diabetes came first: A case-control study

(2012) E. Cereda et al.   NEUROLOGY

Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort

(2012) Mark L. Wahlqvist et al.   PARKINSONISM & RELATED DISORDERS

Weight Gain Is Associated with Medial Contact Site of Subthalamic Stimulation in Parkinson's Disease

(2012) Filip Růžička et al.   PLoS One

A historical justification for and retrospective analysis of the systematic application of light therapy in Parkinson’s disease

(2012) Gregory L. Willis et al.   REVIEWS IN THE NEUROSCIENCES

Decrease in Blood Cortisol Corresponds to Weight Gain following Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson’s Disease

(2012) Evžen Ružicka et al.   STEREOTACTIC AND FUNCTIONAL NEUROSURGERY

The Role of Ghrelin, Neuropeptide Y and Leptin Peptides in Weight Gain after Deep Brain Stimulation for Parkinson’s Disease

(2012) Elli Markaki et al.   STEREOTACTIC AND FUNCTIONAL NEUROSURGERY

Change of the melanocortin system caused by bilateral subthalamic nucleus stimulation in Parkinson’s disease

(2011) F. Escamilla-Sevilla et al.   ACTA NEUROLOGICA SCANDINAVICA

Retracted : Sunlight exposure is important for preventing hip fractures in patients with Alzheimer’s disease, Parkinson’s disease, or stroke

(2011) J. Iwamoto et al.   ACTA NEUROLOGICA SCANDINAVICA

Circadian rhythm of rest activity and autonomic nervous system activity at different stages in Parkinson's disease

(2011) Fumitoshi Niwa et al.   AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL

Diabetes and Risk of Parkinson's Disease: A systematic review and meta-analysis

(2011) E. Cereda et al.   DIABETES CARE

Salivary cortisol levels in Parkinson's disease and its correlation to risk behaviour

(2011) A. Djamshidian et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Once-weekly risedronate for prevention of hip fracture in women with Parkinson's disease: a randomised controlled trial

(2011) Y. Sato et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Leptin, adiponectin, and resistin secretion and diurnal rhythmicity are unaltered in Parkinson's disease

(2011) Nasir Ahmad Aziz et al.   MOVEMENT DISORDERS

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

(2011) Klaus Seppi et al.   MOVEMENT DISORDERS

Decreased expression of Bmal2 in patients with Parkinson's disease

(2011) Hui Ding et al.   NEUROSCIENCE LETTERS

Promoter methylation analysis of seven clock genes in Parkinson's disease

(2011) Qingling Lin et al.   NEUROSCIENCE LETTERS

Body mass index in Parkinson’s disease: A meta-analysis

(2011) Marjolein A. van der Marck et al.   PARKINSONISM & RELATED DISORDERS

Circadian rhythms and cardiovascular health

(2011) Francesco Portaluppi et al.   SLEEP MEDICINE REVIEWS

Assessment of response fluctuations in Parkinson's disease by ambulatory wrist activity monitoring

(2010) J. J. Hilten et al.   ACTA NEUROLOGICA SCANDINAVICA

Serum Vitamin D and the Risk of Parkinson Disease

(2010) Paul Knekt et al.   ARCHIVES OF NEUROLOGY

Weight change following deep brain stimulation for movement disorders

(2010) Roy E. Strowd et al.   JOURNAL OF NEUROLOGY

Postprandial ghrelin response is reduced in patients with Parkinson’s disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson’s disease?

(2010) Marcus M. Unger et al.   JOURNAL OF NEUROLOGY

Low-protein and protein-redistribution diets for Parkinson's disease patients with motor fluctuations: A systematic review

(2010) Emanuele Cereda et al.   MOVEMENT DISORDERS

Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease

(2010) Katharina Wulff et al.   NATURE REVIEWS NEUROSCIENCE

Neural control of feeding behavior: Overview and clinical correlations

(2010) E. E. Benarroch   NEUROLOGY

Circadian Integration of Metabolism and Energetics

(2010) J. Bass et al.   SCIENCE

The extra-hypothalamic actions of ghrelin on neuronal function

(2010) Zane B. Andrews   TRENDS IN NEUROSCIENCES

Leptin and ghrelin concentrations and weight loss in Parkinson’s disease

(2009) U. Fiszer et al.   ACTA NEUROLOGICA SCANDINAVICA

THE CROSSTALK BETWEEN PHYSIOLOGY AND CIRCADIAN CLOCK PROTEINS

(2009) David Duguay et al.   CHRONOBIOLOGY INTERNATIONAL

Dopaminergic treatment is associated with decreased body weight in patients with Parkinson’s disease and dyskinesias

(2009) C. G. Bachmann et al.   EUROPEAN JOURNAL OF NEUROLOGY

Expression of clock genesPer1andBmal1in total leukocytes in health and Parkinson’s disease

(2009) Y. Cai et al.   EUROPEAN JOURNAL OF NEUROLOGY

Modulation of nutritional state in Parkinsonian patients with bilateral subthalamic nucleus stimulation

(2009) Joana Guimarães et al.   JOURNAL OF NEUROLOGY

Ghrelin Promotes and Protects Nigrostriatal Dopamine Function via a UCP2-Dependent Mitochondrial Mechanism

(2009) Z. B. Andrews et al.   JOURNAL OF NEUROSCIENCE

Comparison of weight gain and energy intake after subthalamic versus pallidal stimulation in Parkinson's disease

(2009) Paul Sauleau et al.   MOVEMENT DISORDERS

Daily energy expenditure, physical activity, and weight loss in Parkinson's disease patients

(2009) Evangelia Delikanaki-Skaribas et al.   MOVEMENT DISORDERS

Weight loss, body fat mass, and leptin in Parkinson's disease

(2009) Birgitta Lorefält et al.   MOVEMENT DISORDERS

Weight changes associated with unilateral STN DBS and advanced PD

(2009) Harrison C. Walker et al.   PARKINSONISM & RELATED DISORDERS

Prevalence of Vitamin D Insufficiency in Patients With Parkinson Disease and Alzheimer Disease

(2008) Marian L. Evatt et al.   ARCHIVES OF NEUROLOGY

Overweight after deep brain stimulation of the subthalamic nucleus in Parkinson disease: long term follow-up

(2008) S Bannier et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY